360 related articles for article (PubMed ID: 28615370)
1. Molecular Pathways: Targeting the Microenvironment of Liver Metastases.
Milette S; Sicklick JK; Lowy AM; Brodt P
Clin Cancer Res; 2017 Nov; 23(21):6390-6399. PubMed ID: 28615370
[TBL] [Abstract][Full Text] [Related]
2. Role of the Microenvironment in Liver Metastasis: From Pre- to Prometastatic Niches.
Brodt P
Clin Cancer Res; 2016 Dec; 22(24):5971-5982. PubMed ID: 27797969
[TBL] [Abstract][Full Text] [Related]
3. Evolving landscape of treatments targeting the microenvironment of liver metastases in non-small cell lung cancer.
Zhu L; Yu X; Tang X; Hu C; Wu L; Liu Y; Zhou Q
Chin Med J (Engl); 2024 May; 137(9):1019-1032. PubMed ID: 38251678
[TBL] [Abstract][Full Text] [Related]
4. Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.
Cercek A; Boucher TM; Gluskin JS; Aguiló A; Chou JF; Connell LC; Capanu M; Reidy-Lagunes D; D'Angelica M; Kemeny NE
J Surg Oncol; 2016 Nov; 114(6):655-663. PubMed ID: 27566258
[TBL] [Abstract][Full Text] [Related]
5. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
6. Separation of breast cancer and organ microenvironment transcriptomes in metastases.
Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC
Breast Cancer Res; 2019 Mar; 21(1):36. PubMed ID: 30841919
[TBL] [Abstract][Full Text] [Related]
7. Role of T cells in liver metastasis.
Wu K; Zhang G; Shen C; Zhu L; Yu C; Sartorius K; Ding W; Jiang Y; Lu Y
Cell Death Dis; 2024 May; 15(5):341. PubMed ID: 38755133
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.
Dmello RS; To SQ; Chand AL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669775
[TBL] [Abstract][Full Text] [Related]
9. Systemic treatment of neuroendocrine tumors with hepatic metastases.
Demirkan BH; Eriksson B
Turk J Gastroenterol; 2012; 23(5):427-37. PubMed ID: 23161287
[TBL] [Abstract][Full Text] [Related]
10. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment.
Achyut BR; Yang L
Gastroenterology; 2011 Oct; 141(4):1167-78. PubMed ID: 21839702
[TBL] [Abstract][Full Text] [Related]
12. Gastric cancer-derived LBP promotes liver metastasis by driving intrahepatic fibrotic pre-metastatic niche formation.
Xie L; Qiu S; Lu C; Gu C; Wang J; Lv J; Fang L; Chen Z; Li Y; Jiang T; Xia Y; Wang W; Li B; Xu Z
J Exp Clin Cancer Res; 2023 Oct; 42(1):258. PubMed ID: 37789385
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of the efficacy of microparticle-mediated chemoembolization in liver metastases arising from gastrointestinal tumors.
Li C; Liu Y; Zhou J; Zhang YW
J Cancer Res Ther; 2017; 13(4):642-646. PubMed ID: 28901307
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers.
Fondevila F; Méndez-Blanco C; Fernández-Palanca P; González-Gallego J; Mauriz JL
Exp Mol Med; 2019 Sep; 51(9):1-15. PubMed ID: 31551425
[TBL] [Abstract][Full Text] [Related]
15. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer.
Zhong Y; Macgregor-Das A; Saunders T; Whittle MC; Makohon-Moore A; Kohutek ZA; Poling J; Herbst BT; Javier BM; Cope L; Leach SD; Hingorani SR; Iacobuzio-Donahue CA
Clin Cancer Res; 2017 Mar; 23(6):1607-1620. PubMed ID: 27637888
[No Abstract] [Full Text] [Related]
17. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
[TBL] [Abstract][Full Text] [Related]
18. BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer.
Bartolini A; Cardaci S; Lamba S; Oddo D; Marchiò C; Cassoni P; Amoreo CA; Corti G; Testori A; Bussolino F; Pasqualini R; Arap W; Corà D; Di Nicolantonio F; Marchiò S
Clin Cancer Res; 2016 Oct; 22(19):4923-4933. PubMed ID: 27143691
[TBL] [Abstract][Full Text] [Related]
19. The unique immune microenvironment of liver metastases: Challenges and opportunities.
Ciner AT; Jones K; Muschel RJ; Brodt P
Semin Cancer Biol; 2021 Jun; 71():143-156. PubMed ID: 32526354
[TBL] [Abstract][Full Text] [Related]
20. Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases.
Wang C; Sandhu J; Ouyang C; Ye J; Lee PP; Fakih M
JAMA Netw Open; 2021 Aug; 4(8):e2118416. PubMed ID: 34369992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]